Skip to content
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Hematology · Antiphospholipid Syndrome

Familial Antiphospholipid Syndrome: A Patient Guide

At a Glance

Familial antiphospholipid syndrome reflects complex inherited susceptibility, not a single predictable gene. Diagnosis requires persistent antibodies plus a clot or pregnancy complication, and treatment is individualized, often using warfarin or heparin with low-dose aspirin during pregnancy.

Familial Antiphospholipid Syndrome (APS) is a rare autoimmune condition where the body’s immune system mistakenly produces antibodies that increase the risk of blood clots and pregnancy complications. While it can cluster in families, it is not a “single-gene” disorder that is passed down in a predictable way. Instead, it is a complex, polygenic condition where several different genes create a baseline of susceptibility [1][2]. Having these genetic markers means your “volume” for an immune reaction is turned up, but it does not guarantee that you will ever develop the disease itself.

The behavior of APS is best understood through the “two-hit” model or hypothesis. The first hit is your genetic foundation—the inherited markers that allow these specific antibodies to exist in your blood. However, these antibodies often circulate harmlessly until a second hit occurs. This second hit is an environmental trigger, such as a major infection, surgery, trauma, or the physical stress of pregnancy, which “activates” the antibodies and causes the blood to clot [3][4]. Keep in mind that triggers and risk factors cannot always be avoided, and a clot is not evidence that you failed to manage stress or lifestyle. Because of this, many people may carry the antibodies (known as being an aPL carrier) for their entire lives without ever experiencing a clinical event.

To ensure an accurate diagnosis, doctors follow a strict rule of persistence along with clinical history. Because antibodies can spike temporarily during a common cold or flu, a laboratory finding of APS requires two positive blood tests taken at least 12 weeks apart [5][6]. This confirms the antibodies are a persistent part of your biology rather than a passing reaction to an infection. A full diagnosis of APS requires these lab results plus a compatible clinical event, like a clot or pregnancy morbidity. Once diagnosed, the focus shifts to long-term protection, which often involves long-term blood-thinning medication depending on individualized factors. Never stop your blood thinner without your prescriber’s direction.

The standard of care for preventing future clots is the use of Vitamin K Antagonists, most commonly Warfarin. While newer “no-test” blood thinners called DOACs are popular for other conditions, they are generally avoided in APS—especially for those with “triple-positive” antibodies or a history of arterial clots—because they have been shown to be less effective at preventing strokes in this specific population [7][8]. For pregnancy, the strategy changes to using Heparin and low-dose aspirin to protect both the parent and the developing placenta [9].

In very rare cases, the syndrome can escalate into an emergency called Catastrophic APS (CAPS), where clots form in multiple organs over a few days. While frightening, this affects fewer than 1% of patients and is managed with intensive hospital care [10][11]. For the vast majority of patients, living with APS means staying vigilant with monitoring, managing heart-health risks like blood pressure, and working closely with a specialist to keep your immune system as stable as possible.

Common questions in this guide

Is familial antiphospholipid syndrome passed down from a parent?
Antiphospholipid syndrome can cluster in families because several inherited factors may increase susceptibility. It is not usually caused by one gene passed down in a predictable pattern, and having these inherited markers does not guarantee that you will develop the condition.
How is antiphospholipid syndrome diagnosed?
Diagnosis requires a compatible clinical event, such as a blood clot or pregnancy complication, together with persistent antiphospholipid antibodies. The antibodies must be detected on two blood tests taken at least 12 weeks apart because infections can cause temporary positive results.
What does the two-hit model mean in familial APS?
The first hit is an inherited tendency that allows antiphospholipid antibodies to develop. A second hit, such as a major infection, surgery, trauma, or pregnancy, may activate the antibodies and contribute to clotting. Some people carry the antibodies for life without having a clinical event.
Is warfarin safer or more effective than a DOAC for APS?
Warfarin is commonly used to prevent future clots in antiphospholipid syndrome. DOACs are generally avoided in APS, especially when all three major antibody tests are positive or when a person has had an arterial clot, because they may provide less protection against stroke. Do not change or stop a blood thinner without your prescriber's direction.
What medicines are used for antiphospholipid syndrome during pregnancy?
Pregnancy care commonly uses heparin and low-dose aspirin to reduce clotting risk and support the developing placenta. The exact plan depends on your medical and pregnancy history, so it should be coordinated with your healthcare team.
What is catastrophic antiphospholipid syndrome, and how common is it?
Catastrophic antiphospholipid syndrome is a rare emergency in which clots form in multiple organs over several days. It affects fewer than 1% of people with antiphospholipid syndrome and requires intensive hospital treatment.
What should I do if I need surgery or develop a major infection with APS?
Tell the treating team about your antiphospholipid syndrome, antibody profile, and blood thinner before surgery or urgent treatment for a major infection. Your clinicians can create an individualized plan to reduce clotting risk and watch for serious complications, including catastrophic APS.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my family history and antibody profile, what is my individual risk of a 'second hit' event?
  2. 2.How does my specific antibody status—single, double, or triple positive—affect the choice of blood thinner?
  3. 3.If I am currently on a DOAC, should we reconsider switching to Warfarin for better protection?
  4. 4.What are the specific 'red flag' symptoms I should teach my family members to look for?
  5. 5.If I have a surgery or a major infection, how will my care change to prevent an APS flare or CAPS?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Genetics of Antiphospholipid Syndrome.

    Ortiz-Fernández L, Sawalha AH

    Current rheumatology reports 2019; (21(12)):65 doi:10.1007/s11926-019-0869-y.

    PMID: 31807905
  2. 2

    Genetic aspects of the antiphospholipid syndrome: An update.

    Sebastiani GD, Iuliano A, Cantarini L, Galeazzi M

    Autoimmunity reviews 2016; (15(5)):433-9.

    PMID: 26804759
  3. 3

    Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome.

    Yang L, Guo R, Liu H, et al.

    Frontiers in immunology 2025; (16()):1527554 doi:10.3389/fimmu.2025.1527554.

    PMID: 40181965
  4. 4

    An Update on Antiphospholipid Syndrome.

    Xourgia E, Tektonidou MG

    Current rheumatology reports 2022; (23(12)):84 doi:10.1007/s11926-021-01051-5.

    PMID: 34985625
  5. 5

    Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies.

    Tufano A, Di Minno MND, Guida A, et al.

    Seminars in thrombosis and hemostasis 2019; (45(5)):468-477 doi:10.1055/s-0039-1692702.

    PMID: 31216589
  6. 6

    [Laboratory diagnosis of antiphospholipid syndrome: From criteria to practice].

    Joste V, Dragon-Durey MA, Darnige L

    La Revue de medecine interne 2018; (39(1)):34-41 doi:10.1016/j.revmed.2017.02.006.

    PMID: 28302338
  7. 7

    Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines.

    Pastori D, Menichelli D, Cammisotto V, Pignatelli P

    Frontiers in cardiovascular medicine 2021; (8()):715878 doi:10.3389/fcvm.2021.715878.

    PMID: 34414220
  8. 8

    Antiphospholipid Syndrome: State of the Art of Clinical Management.

    Depietri L, Veropalumbo MR, Leone MC, Ghirarduzzi A

    Cardiovascular drugs and therapy 2025; (39(2)):385-404 doi:10.1007/s10557-023-07496-3.

    PMID: 37572208
  9. 9

    Obstetric antiphospholipid syndrome.

    Soto-Peleteiro A, Gonzalez-Echavarri C, Ruiz-Irastorza G

    Medicina clinica 2024; (163 Suppl 1()):S14-S21 doi:10.1016/j.medcli.2024.05.001.

    PMID: 39174149
  10. 10

    Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?

    Moyon Q, Mathian A, Papo M, et al.

    Current rheumatology reports 2024; (26(7)):269-277 doi:10.1007/s11926-024-01148-7.

    PMID: 38652403
  11. 11

    Catastrophic antiphospholipid syndrome: a CAPS-tivating hematologic disease.

    Salter BM, Crowther MA

    Hematology. American Society of Hematology. Education Program 2024; (2024(1)):214-221 doi:10.1182/hematology.2024000544.

    PMID: 39644034

This page is for informational purposes only and does not constitute medical advice. Discuss antibody testing, blood thinners, pregnancy care, and surgery planning with your healthcare team.

Get notified when new evidence is published on familial antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.